Sabby Management LLC bought a new stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 334,622 shares of the medical technology company’s stock, valued at approximately $629,000. Sabby Management LLC owned approximately 3.03% of Alphatec Holdings at the end of the most recent quarter.

Separately, Fondren Management LP lifted its holdings in shares of Alphatec Holdings by 20.8% during the 2nd quarter. Fondren Management LP now owns 220,534 shares of the medical technology company’s stock valued at $408,000 after acquiring an additional 37,933 shares in the last quarter. Institutional investors own 20.56% of the company’s stock.

WARNING: “Sabby Management LLC Takes $629,000 Position in Alphatec Holdings, Inc. (ATEC)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/10/17/sabby-management-llc-takes-629000-position-in-alphatec-holdings-inc-atec.html.

ATEC has been the topic of several recent research reports. ValuEngine lowered shares of Alphatec Holdings from a “sell” rating to a “strong sell” rating in a report on Thursday, August 17th. Lake Street Capital initiated coverage on shares of Alphatec Holdings in a report on Monday. They set a “buy” rating and a $7.00 target price on the stock. Finally, HC Wainwright initiated coverage on shares of Alphatec Holdings in a report on Monday, August 14th. They set a “buy” rating and a $4.00 target price on the stock.

Alphatec Holdings, Inc. (NASDAQ ATEC) traded up 0.8410% during trading on Tuesday, hitting $3.7412. 41,210 shares of the company traded hands. Alphatec Holdings, Inc. has a one year low of $1.58 and a one year high of $6.98. The firm’s market cap is $41.33 million. The firm has a 50 day moving average of $2.56 and a 200 day moving average of $2.08.

Alphatec Holdings (NASDAQ:ATEC) last posted its earnings results on Thursday, August 10th. The medical technology company reported ($0.32) EPS for the quarter. The business had revenue of $24.38 million for the quarter. On average, analysts expect that Alphatec Holdings, Inc. will post ($1.20) earnings per share for the current fiscal year.

About Alphatec Holdings

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Institutional Ownership by Quarter for Alphatec Holdings (NASDAQ:ATEC)

Receive News & Stock Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related stocks with our FREE daily email newsletter.